Geviti Inc — SEC Form D Filing
Geviti Inc filed an SEC Form D on September 15, 2026, reporting $1.61M raised in Other.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 15, 2026
- Amount reported
- $1.61M
- Round stage
- Seed because a $1.6 million equity raise is characteristic of an early-stage company scaling its initial product offering and expanding its clinical network.
- Industry
- Other
- Website
- https://www.geviti.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Traditional healthcare systems focus on reactive treatment of disease rather than proactive optimization of individual healthspan and vitality.
Solution
Geviti delivers a comprehensive telehealth platform offering at-home blood diagnostics, personalized biomarker analysis, and direct-to-consumer access to longevity therapies and custom supplements.
Why now
Consumers are increasingly taking control of their own health data amidst a cultural shift toward preventative wellness and the rapid normalization of specialized telehealth services.
Source: SEC EDGAR Form D filing